These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 4421949

  • 1. [Influence of the vaccinal status on the clinical form and results of patients with smallpox].
    Kecmanović M, Suvaković V.
    Med Pregl; 1974; 27(1-2):13-9. PubMed ID: 4421949
    [No Abstract] [Full Text] [Related]

  • 2. The effect of the number of incisions used in primary vaccination against smallpox on the intensity of antibody formation: a preliminary communication.
    Shneyderman AE, Petranovskaya MR, Marennikova SS.
    J Hyg Epidemiol Microbiol Immunol; 1973 Mar; 17(3):257-60. PubMed ID: 4795563
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Development of vaccination immunity in hospital personnel revaccinated at three-year intervals.
    Nyerges G, Hollós I, Losonczy G, Erdös L, Petrás G.
    Acta Microbiol Acad Sci Hung; 1972 Mar; 19(1):63-8. PubMed ID: 4651044
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Protective and control measures in imported smallpox epidemics].
    Wasserstrom T.
    Zentralbl Bakteriol Orig; 1966 Jan; 199(1):32-8. PubMed ID: 4293173
    [No Abstract] [Full Text] [Related]

  • 10. [Determination of the duration of post-vaccinal smallpox immunity by means of hemagglutination-inhibiting antibodies].
    Topciu V, Plavosin-Babusceac L, Csaky N, Reichrath S.
    Arch Hyg Bakteriol; 1968 Dec; 152(5):422-6. PubMed ID: 5754319
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Vaccination against smallpox in the United States--a re-evaluation of the risks and benefits.
    Reeve AM.
    J Iowa Med Soc; 1971 Nov; 61(11):655-7. PubMed ID: 5115181
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The immunity to vaccina virus of Japanese people of different age groups: serum antibody titre and local skin reaction at the site of vaccination.
    Kitaoka M, Nishimura C, Kimura M.
    Prog Immunobiol Stand; 1970 Nov; 4():683-91. PubMed ID: 5482206
    [No Abstract] [Full Text] [Related]

  • 20. [Methisazone (Marboran) in the prevention of smallpox and in the treatment of the complications of smallpox vaccination. Review].
    Bianchini C.
    Arch Ital Sci Med Trop Parassitol; 1969 Nov; 50(1):29-38. PubMed ID: 5770701
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.